MONTREAL, Aug. 1, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:
AEZS) (TSX: AEZ) (the "Company") will announce its second quarter 2013
financial and operating results after market close on Thursday, August
8, 2013. The Company will host a conference call to discuss these
results on Friday, August 9, 2013, at 8:30 a.m., Eastern Time.
Participants may access the live webcast via the Company's website at www.aezsinc.com in the "Newsroom" section, or by telephone using the following numbers:
in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191.
A replay of the webcast will also be available on the Company's website
for a period of 30 days.
About Aeterna Zentaris
Aeterna Zentaris is a specialty biopharmaceutical company engaged in
developing novel treatments in oncology and endocrinology. The
Company's pipeline encompasses compounds from drug discovery to
regulatory approval. For more information, visit www.aezsinc.com.
SOURCE Aeterna Zentaris Inc.